V
Vapotherm
Develops and manufactures innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders
About Vapotherm
Vapotherm is a medical technology company specializing in advanced respiratory care solutions. The company provides high velocity therapy, a form of non-invasive ventilation (NIV) that offers ventilatory support without the need for a mask. This technology is particularly beneficial for patients who are mask intolerant, providing a more comfortable and effective alternative to traditional methods. Vapotherm's products are used across various patient populations, from adults with chronic obstructive pulmonary disease (COPD) in emergency departments to delicate infants in neonatal intensive care units (NICU). The company serves a wide range of healthcare providers, including hospitals and emergency care facilities, and has treated over 3.3 million patients globally. Vapotherm operates in the medical device market, focusing on respiratory care. Its business model revolves around the sale of its high velocity therapy systems and related consumables, generating revenue through both initial equipment sales and ongoing supply of disposable components. The company is backed by extensive clinical research and is trusted by over 2,200 hospitals worldwide.
Source: Dealroom company dataAt a glance
- Founded
- 1999
- Headquarters
- Exeter, United Kingdom
- Listing
- IPO 2018
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Vapotherm.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Gilde Healthcare
Series B and later11 investors entered at this stage
GE Asset Management
Kaiser Permanente Ventures
QuestMark Partners
Integral Capital Partners
SightLine Partners
Adage Capital
Crestline Investors
Arnerich Massena
Perceptive Advisors
Redmile Group
CIBC Innovation Banking
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
39 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vapotherm on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vapotherm on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.